The combined use of cmyb antisense oligonucleotide and vascular endothelial growth factor gene for preventment and treatment of restenosis after angioplasty
Author:
Affiliation:

Clc Number:

R 654.3

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To investigate the effect of combined use of antisense oligonucleotide (cmyb ASON) and vascular endothelial growth factor (VEGF) on restenosis after angioplasty.
    :Methods :China rabbits were randomly divided to control group, VEGF treatment group, cmyb ASON treatment group, cmyb ASON +VEGF treatment group. Each group consisted of 7 rabbits with the same lesion of left common carotid artery. Evaluation on restenosis was done by pathological section and immunohistochemistry, and WesternBlotting for the expression of PCNA.
    :Results:All groups had varying degrees of vascular endothelial and smooth muscle hyperplasia, especially in control group. The hyperplasia in cmyb ASON and VEGF groups were better than control group (P<0.01), and cmyb ASON + VEGF combination group was baller than cmyb ASON or VEGF groups (P<0.01). The results of WesternBlotting were similar to those of pathological section.
    :Conclusions:Combined use of cmyb ASON and VEGF has definite effect in preventing restenosis after angioplasty, but cmyb ASON and VEGF do not have interrelated synergism.

    Reference
    Related
    Cited by
Get Citation

ZHANG Tiemin, ZHAO Xianqi, YANG Yuchuan, SHI Chunying, CHEN Ying, GUO Xin, PIAO Daxun, JIANG Hongchi.The combined use of cmyb antisense oligonucleotide and vascular endothelial growth factor gene for preventment and treatment of restenosis after angioplasty[J]. Chin J Gen Surg,2008,17(12):11-120.
DOI:10.7659/j. issn.1005-6947.2008.12.011

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 01,1900
  • Revised:January 01,1900
  • Adopted:
  • Online: December 25,2008
  • Published: